Feasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction

Claudia Angela Maria Fulgenzi; Antonio D’Alessio; Bernhard Scheiner; Naoshi Nishida; Celina Ang; Thomas U. Marron; Linda Y. Wu; Anwaar Saeed; Brooke Wietharn; Antonella Cammarota; Tiziana Pressiani; Matthias Pinter; Rohini Sharma; Jaekyung Cheon; Yi‐Hsiang Huang; Pei‐Chang Lee; Samuel Phen; Anuhya Gampa; Anjana Pillai; Andrea Napolitano; Caterina Vivaldi; Francesca Salani; Gianluca Masi; Dominik Bettinger; Robert Thimme; Arndt Vogel; Martin Schoenlein; Kornelius Schulze; Johann von Felden; Henning Wege; Peter R. Galle; Mario Pirisi; Joong‐Won Park; Masatoshi Kudo; Lorenza Rimassa; Amit G. Singal; Alessio Cortellini; Hong Jae Chon; Giorgia Ghittoni; Calogero Cammà; Benedetta Stefanini; Franco Trevisani; Edoardo G. Giannini; David J. Pinato

doi:10.1016/s0168-8278(23)01390-9

Related publications

Article2024

Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction

Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D’Alessio, Aman Mehan, Giulia Francesca Manfredi, Ciro Celsa, Naoshi Nishida, Celina Ang, Thomas U. Marron, Linda Y. Wu, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Matthias Pinter, Rohini Sharma, Jaekyung Cheon, Yi‐Hsiang Huang, Pei‐Chang Lee, Samuel Phen, Anuhya Gampa, Anjana Pillai, Andrea Napolitano, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Marianna Silletta, Federica Lo Prinzi, Emanuela Di Giacomo, Bruno Vincenzi, Dominik Bettinger, Robert Thimme, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Mario Pirisi, Joong‐Won Park, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Paul El Tomb, Susanna V. Ulahannan, Alessandro Parisi, Hong Jae Chon, Wei-Fan Hsu, Giorgia Ghittoni, Calogero Cammà, Benedetta Stefanini, Franco Trevisani, Edoardo G. Giannini, Alessio Cortellini, David J. Pinato

Article2023

PD-16 Atezolizumab plus bevacizumab is associated with improved survival outcomes in HCC patients with Child-Pugh B dysfunction compared to best supportive therapy

Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Bernhard Scheiner, Celina Ang, Brooke Wietharn, Matthias Pinter, Naoshi Nishida, Alessandro Parisi, Yi‐Hsiang Huang, Dominik Bettinger, Arndt Vogel, M. Silletta, Martin Schönlein, Peter R. Galle, Masatoshi Kudo, Amit G. Singal, Alessio Cortellini, Hong Jae Chon, Bernardo Stefanini, E. Giannini, David J. Pinato

Article2015

Abstract CT120: Axitinib safety and pharmacokinetics in Child-Pugh A and Child-Pugh B patients with advanced hepatocellular cancer

Yoon‐Koo Kang, Tara Elisabeth Seery, Mina Kato, Debasis Chakrabarti, Olga Valota, Ying Chen, Jie Tang, Yazdi K. Pithavala, Masatoshi Kudo

Article2019

Pembrolizumab (Pembro) therapy vs best supportive care (BSC) in advanced hepatocellular carcinoma (HCC): KEYNOTE-240

Richard S. Finn, Baek‐Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, В. В. Бредер, Julien Edeline, Yee Chao, Sadahisa Ogasawara, Thomas Yau, Marcelo Garrido, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Scot Ebbinghaus, E. Chen, A.B. Siegel, Andrew X. Zhu, Ann‐Lii Cheng

Article2014

Randomised Study of Axitinib (Axi) Plus Best Supportive Care (Bsc) Versus Placebo (Pbo) Plus Bsc in Patients with Advanced Hepatocellular Carcinoma (Hcc) Following Prior Antiangiogenic Therapy

Y-K. Kang, Thomas Yau, Jung‐Won Park, Éveline Boucher, Ho Yeong Lim, Ronnie T. P. Poon, T‐Y Lee, Shuntaro Obi, Sze Ling Chan, Shukui Qin, R.D. Kim, Jie Tang, Olga Valota, D. Chakrabarti, Masatoshi Kudo